Background: Individual differences in human perception of sweetness are partly due to genetics; however, which genes are associated with the perception and the consumption of sweet substances remains unclear. Objective: The aim of this study was to verify previous reported associations within genes involved in the peripheral receptor systems (i.e., TAS1R2, TAS1R3, and GNAT3) and reveal novel loci. Methods: We performed genome-wide association scans (GWASs) of the perceived intensity of 2 sugars (glucose and fructose) and 2 high-potency sweeteners (neohesperidin dihydrochalcone and aspartame) in an Australian adolescent twin sample (n = 1757), and the perceived intensity and sweetness and the liking of sucrose in a US adult twin sample (n = 686). We further performed GWASs of the intake of total sugars (i.e., total grams of all dietary mono-and disaccharides per day) and sweets (i.e., handfuls of candies per day) in the UK Biobank sample (n = ≤174,424 white-British individuals). All participants from the 3 independent samples were of European ancestry. Results: We found a strong association between the intake of total sugars and the single nucleotide polymorphism rs11642841 within the FTO gene on chromosome 16 (P = 3.8 × 10 −8 ) and many suggestive associations (P < 1.0 × 10 −5 ) for each of the sweet perception and intake phenotypes. We showed genetic evidence for the involvement of the brain in both sweet taste perception and sugar intake. There was limited support for the associations with TAS1R2, TAS1R3, and GNAT3 in all 3 European samples. Conclusions: Our findings indicate that genes additional to those involved in the peripheral receptor system are also associated with the sweet taste perception and intake of sweet-tasting foods. The functional potency of the genetic variants within TAS1R2, TAS1R3, and GNAT3 may be different between ethnic groups and this warrants further investigations.
Introduction
The perception of and liking for a given degree of sweetness vary between individuals. Twin studies have shown that heritabilities (h 2 ) of preferences for sucrose solution and sweet foods range from low (1, 2) to moderate (3, 4) (h 2 = 0.23-0.40). Our twin study (5) showed moderate heritability on the perceived intensities of the monosaccharides glucose (h 2 = 0.31) and fructose (h 2 = 0.34) and of the high-potency sweeteners neohesperidin dihydrochalcone (NHDC; h 2 = 0.31) and aspartame (h 2 = 0.30); a common genetic factor accounted for >75% of the genetic variance in each sweet taste. However, the particular genes and genetic variants that are responsible for variation in human sweet taste perception and the intake of sweet foods remain largely underexplored.
Previous studies reported that genetic variants within or near sweet taste receptor genes TAS1R2 (6) and TAS1R3 (7) , and a downstream gene, GNAT3 (8) , are associated with the variance of sucrose sensitivity (i.e., the ability to discriminate between sucrose solutions of different concentrations). Variants within TAS1R2 were also shown to be associated with the intake of sugars and sweet foods in both children (9) (10) (11) and adults (6, (12) (13) (14) . Although variants within TAS1R3 were not associated with the intake of sweet foods (9, 12, 15) , they were found to be associated with the preference for sucrose solutions (16) . Other genetic variants reported to be associated with sugar consumption are within the glucose transporter gene GLUT2 (13, 17) (also known as SLC2A2) and the fibroblast growth factor gene FGF21 (18) (19) (20) (21) . Notably, except for the association with FGF21 which was identified in large genome-wide association studies, these associations with both sweet taste perception and intake of sweet substances were reported in studies of small sample sizes (n ≤ 160 and 1037, respectively) and some studies (7, 8, 13, 17) were even comprised of mixed ethnicities (i.e., Caucasians, Asians, and African Americans) so they remain to be validated in larger independent samples. A summary of these associations is presented in Table 1 .
To verify previously reported associations and reveal novel loci, we performed genome-wide association scans (GWASs) of sweet taste perception (primary outcome variables) in an Australian adolescent twin sample (n = 1757) and a US adult twin sample (n = 686), and the intake of sugars and sweets (i.e., candies) (secondary outcome variables) in the UK Biobank sample (n = ≤174,424) (22) . We also looked for evidence for genetic variation in biological pathways and compared the expression levels of associated genes in different human tissues including taste buds and brain tissues.
Methods
This article used the STrengthening the REporting of Genetic Association Studies (STREGA) reporting guidelines (23) .
Samples
The Australian sample was a subset of participants from the Brisbane Adolescent Twin Study (24) , also referred to as the Brisbane Longitudinal Twin Study, who performed the taste test between 2003 and 2014. Most twins performed the taste test at age 14 y but with older siblings the mean ± SD age of the sample was older (16.1 ± 2.7 y). Zygosity was determined from genome-wide genotyping. The US sample was a subset of adult twins who performed the taste test at the annual Twins Days Festival at Twinsburg, Ohio, between 2009 and 2015. Only Caucasians were included in the present study. Zygosity was assessed with 3 methods: self-reported identity, experimenter ratings of photographs for physical similarity, and genome-wide genotyping. The UK Biobank recruited 502,650 participants (aged 37-73 y; 54.4% female; 5% of those invited) from 21 centers across England, Wales, and Scotland between 2006 and 2010 (22) . Intake of total sugars was available for 211,051 participants and intake of sweets was available for a subsample of 25,533 participants.
Ethical statement
The Australian study was approved by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee. The US study was approved by the Institutional Review Board (#4) of the University of Pennsylvania. The UK Biobank study was approved by the UK National Health Service National Research Ethics Service. Written consent was obtained from both the participants and their parents (for subjects younger than 18 y old).
Taste test in the Australian and US samples
For the Australian sample, detailed information on the taste test and data processing has been described previously (5) . Briefly, the taste battery included duplicated presentations of 4 sweet (0.60 M glucose, 0.30 M fructose, 8.0 × 10 −5 M NHDC, and 1.4 × 10 −3 M aspartame) and 5 bitter (propylthiouracil, sucrose octaacetate, quinine, caffeine, and denatonium benzoate) solutions, plus 2 water solutions as controls. The 20 samples were presented in random order. Participants were instructed to rate their perceived intensity for each solution using a general labeled magnitude scale (gLMS) (25) , with labels of no sensation (0 mm), barely detectable (2 mm), weak (7 mm), moderate (20 mm), strong (40 mm), very strong (61 mm), and strongest imaginable (114 mm). Mean intensity ratings from the duplicate presentations for each stimulus were used in the present study. Because the perceived intensity of the 4 sweeteners was highly correlated at the genetic level (genetic correlation [r g ] = 0.78-0.89) and most of the phenotypic variance (71% for glucose, 77% for fructose, 64% for NHDC, and 59% for aspartame) was accounted for by a common factor, as shown in our previous multivariate variance component analysis (5), we further calculated a general sweet factor score (gSweet, a mean intensity of the 4 sweet tastes weighted by loadings from the common factor). A total of 5 phenotypes-perceived intensity of glucose, perceived intensity of fructose, perceived intensity of NHDC, perceived intensity of aspartame, and gSweet-from the Australian sample were analyzed. For the US sample, as described previously (2), participants tasted sweet (sucrose), bitter (phenylthiocarbamide and quinine), sour (citric acid), and salty (sodium chloride and potassium chloride) solutions, and other tastes (e.g., vegetable juice) and rated perceived sweetness, bitterness, sourness, saltiness, burn, intensity, and liking using a 7.7-cm visual analog scale (VAS). A total of 3 phenotypesperceived intensity, perceived sweetness, and liking of the 0.35 M (i.e., 12% wt:vol) sucrose solution-were included in the present study. The 3 phenotypes were weakly to moderately correlated (phenotypic correlation [r p ] = 0.21-0.43) (2).
Intake of total sugars and sweets in the UK Biobank sample
UK Biobank is a large long-term biobank study from the United Kingdom that aims to identify the contribution of genetic and environmental factors to disease. Detailed information on (13) Higher intake of sugar (grams per day).
P5: 312 children (43.2% white) from a Brazilian cohort (9) Higher sugar intake (kilocalories per day) at age 3.9 y; no association at ages 1.1 and 7.7 y. P2 (12) Higher intake of sweets (grams) in an ad libitum meal session ≤ 40 min. P6: 441 adults 2 from a Mexican cohort (14) Lower intake of carbohydrate (grams per day) and percentage energy intake from carbohydrate. P7: 47 children (87.5% Caucasian) from the Guelph Family Health Study (10) Higher percentage energy intake from snacks.
P1-1 (6)
No association with sucrose sensitivity and sugar intake (grams per day). P3 (7) No association with sucrose sensitivity. No association with sucrose detection threshold and percentage energy intake from added sugar. P5 (9) No association with sugar intake (kilocalories per day). P2 (12) No association with percentage energy intake from carbohydrate or intake of sweets (grams) in an ad libitum meal session ≤ 40 min. 1 SNP:allele, SNP and the effect allele. Each study population is given a number (e.g., P1) along with reporting its sample size and ethnicity (as provided in the original study) when it is referred to the first time. P1-1 and P1-2 are from the same study cohort but the sample size of P1-2 is bigger. SNP, single nucleotide polymorphism.
2 Unknown ethnicity. 3 Unknown effect allele.
phenotyping and genotyping is presented elsewhere (22 
Genotyping, imputation, and quality control
For the Australian sample, genotyping was performed with the Illumina 610-Quad BeadChip for 1255 participants and HumanCoreExome-12 version 1.0 BeadChip for 502 participants. Single nucleotide polymorphisms (SNPs) were phased using ShapeIT (26) and then imputed using Minimac3 (27) and the Haplotype Reference Consortium of Caucasian European ancestry (Release 1) (28), with 7,035,128 SNPs passing quality control (QC) as outlined previously (29) . To ensure SNPs were imputed with high data quality, we excluded those with a call rate < 90%, minor allele frequency < 0.05, imputation score < 0.3, and Hardy-Weinberg equilibrium score of P < 1.0 × 10 −6 , with a total of 4,381,914 SNPs remaining. Individuals who were >6 SDs from the centroid of the first 2 genetic principal components (PCs) PC1 and PC2 were excluded, so the sample was of exclusively European ancestry. For the US sample, genotyping was performed using the HumanOmniExpressExome-8 version 1-2 Chip and imputed using 1000 Genome Phase 1 integrated Haplotype, with 6,175,124 SNPs passing QC. With the same post-imputation QC criteria, 5,833,901 SNPs were used in the analyses. The Australian and US samples had a total of 4,001,140 SNPs in common. All UK Biobank participants have been genotyped using the Affymetrix UK BiLEVE Axiom array or Affymetrix UK Biobank Axiom array comprising 805,426 markers in the official release. Imputations were performed using IMPUTE2 and UK10K haplotype and Haplotype Reference Consortium reference panels, as described elsewhere (22) . SNPs with a call rate < 90%, minor allele frequency < 0.01, imputation score < 0.3, and Hardy-Weinberg equilibrium score of P < 1.0 × 10 −6 were excluded, with a total of 10,353,649 SNPs remaining in the analyses. Only participants who classified as white British, determined by similarity of genetic PC values (PC1, PC2), were included in the present study.
Statistical analysis
The genome-wide association analysis for each of the 5 phenotypes from the Australian study and 3 phenotypes from the US study was conducted using genome-wide efficient mixedmodel association (30) . As described previously (31) , this method fits a linear mixed model for each SNP and uses the genetic relatedness matrix, calculated from genome-wide genotyping data, to account for the relatedness of individuals (i.e., twins and siblings from the same family). For the Australian sample, the covariates included age, sex, and the history of ear infection, previously shown to be associated with taste intensity ratings of this sample (5) , and the first 5 genetic PCs. Before modeling, a square root transformation was applied to each of the 5 intensity scores to obtain a more normal distribution (32) . For the US sample, the covariates included age, sex, and the first 2 genetic PCs. A meta-analysis of the perceived intensity was performed using the Australian gSweet scores and the US sucrose intensity scores and the P value-based approach weighted by sample size implemented in the software METAL (33) . The GWASs of the intake of total sugars and sweets in the UK Biobank were performed using BOLT-LMM (34) . This fits a linear mixed model by including a genetic relation matrix derived from genotyped SNPs as a random effect to correct for population structure and cryptic relatedness. Covariates included age, sex, and the first 10 genetic PCs. Because the associations between TAS1R2 and the intake of sugars were suggested to depend on BMI (in kg/m 2 ) (6, 13), we also performed analyses including BMI as an extra covariate or stratifying the sample into 2 groups based on a cutoff of BMI = 25. To ensure that any potential technical or population stratification artifacts had a negligible impact on the results, we calculated the genomic inflation factor (λ) for the Australian and the US phenotypes (λ ranged between 0.99 and 1.02). As λ can be inflated by a large sample size, we calculated the linkage disequilibrium (LD) score regression intercepts (35) for the UK Biobank phenotypes; intercepts of 1.05 and 1.01 for the intake of total sugars and sweets, respectively, indicated little or no population stratification. See Supplemental Figure 1 for Q-Q plots. A priori suggestive and significance thresholds were set at P = 1.0 × 10 −5 and 5.0 × 10 −8 , respectively. Given that the sweet phenotypes were correlated within each sample (2, 5), we estimated the number of independent tests to be 2.62, 2.66, and 1.49 for the Australian, the US, and the UK Biobank sample, respectively, using a matrix spectral decomposition algorithm (36) ; the Bonferroni-corrected significance thresholds became P = 1.9 × 10 −8 , 1.9 × 10 −8 , and 3.4 × 10 −8 , respectively. Manhattan and Q-Q plots were created using FUMA-GWAS (37) . Regional associational plots were created using LocusZoom (38) .
Gene-based association analyses were performed by summarizing the SNP association results at the gene level. The contribution of each SNP to the gene-based association was adjusted by the LD between SNPs within a gene. This was done using the function "fastBAT" implemented in the software GCTA (39) . With 24,765 genes provided in the Genome Reference Consortium Human Build 37 (GRCh37/hg19) and the number of independent phenotypes for each of the Australian, the US, and the UK Biobank samples, conservative Bonferroni-corrected thresholds were set at P = 7.7 × 10 −7 , 7.6 × 10 −7 , and 1.4 × 10 −6 , respectively. Further, we examined the associations between phenotypes (predicted by GWAS results) and gene expression levels (predicted by expression quantitative trait loci, i.e., the associations between SNPs and gene expression levels, results from the GTEx project [40] ) using MetaXcan (41) . With a library of 44 tissue models (including the "cross-tissue" model) from the GTEx project (40) , the maximum number of 11,440 genes expressed per tissue, and the number of independent phenotypes for each of the Australian, the US, and the UK Biobank samples, conservative Bonferroni-corrected thresholds were set at P = 3.8 × 10 −8 , 3.7 × 10 −8 , and 6.6 × 10 −8 , respectively. Tissue enrichment and pathway analyses were performed with methods implemented in DEPICT version 1.1 (42) . The preference was to use only genome-wide significant SNPs if there were ≥10 independent associations with P < 5.0 × 10 −8 . Owing to the lack of genome-wide significant signals, we used SNPs with P < 1.0 × 10 −5 . For traits with <10 independent loci with P < 1.0 × 10 −5 (i.e., perceived intensity of glucose, fructose, aspartame, and the meta-analysis results), we included SNPs with P < 1.0 × 10 −4 . We set the Bonferroni-corrected thresholds for tissue-enrichment analysis at P = 9.1 × 10 −5 , 9.0 × 10 −5 , and 1.6 × 10 −4 for the Australian, the US, and the UK Biobank sample, respectively, and for pathways analysis at P = 1.3 × 10 −6 , 1.3 × 10 −6 , and 2.3 × 10 −6 for the Australian, the US, and the UK Biobank sample, respectively (considering the number of independent phenotypes in each sample and assuming that gene expressions in all 209 tissue/cell samples are independent, and all 14,463 pathways are independent), and the false discovery rate at <0.05.
We calculated the genetic correlations between the intake of total sugars and sweets, and BMI in the UK Biobank sample using the online platform LD hub (43) , which takes the GWAS summary results to perform LD score regression and estimate the genetic correlation between 2 traits (44).
Gene expression
For genes near the identified SNPs or genes identified in genebased or pathway analyses, we examined their expression levels in 31 different tissues using our in-house data of human taste tissues and the publicly available data from GTEx (version 7, 30 general tissue types) (40) . For the in-house assay, we collected 6 taste samples from human fungiform papillae of adults (5 men and 1 woman) using published procedures (45) and isolated the RNA following the manufacturer's directions for processing the taste tissue with Quick-RNA MiniPrep R1054 (Zymo Research). We evaluated RNA quality expressed as an RNA integrity number using the Agilent 2200 TapeStation system (Agilent Technologies). The 6 samples with sufficient RNA quality, as determined by the Next-Generation Sequencing Core of the University of Pennsylvania (RNA integrity number > 7), underwent library preparation and sequencing (100 base pairs single-end) on the HiSeq 4000 sequencer (Illumina) using the manufacturer's sequencing protocols. We mapped reads to the reference genome (GRCh38.p10) after the raw sequence data in fastq format passed quality filters of Trimmomatic (46) and we normalized the counts using the R (The R foundation for Statistical Computing) package ballgown (47), with the median expression level for each gene used in the analyses. The expression levels (e.g., reads per kilo base per million mapped reads and transcript per million) for all genes in all tissue types were winsorized at 1 and 50 and then log2 transformed and presented in a heatmap.
Results

Sample characteristics
The main characteristics of the 3 samples of European ancestry are summarized in Table 2 , together with the sweet phenotypes measured in each sample. The Australian adolescent sample was younger than the US and the UK Biobank samples. There were more female than male participants in all 3 samples. For the Australian sample, the mean intensity ratings for all sweet solutions were between "moderate" and "strong" on the gLMS. The US adults rated perceived intensity of the sucrose solution slightly below the middle point on the VAS and the perceived sweetness and liking of the same solution toward the upper end of the scale. Among all UK Biobank participants who reported their intake data, ∼83% were white British and these were included in the GWAS. See Supplemental Figure 2 for participant flowcharts showing the selection process for the participants from each sample.
GWAS
The strongest association was between the intake of total sugars in the UK Biobank sample and rs11642841 within the FTO gene on chromosome 16 (Figure 1, Supplemental Table  1 ). This variant within FTO was one of the first variants to be associated with BMI in genome-wide analyses and has been repeatedly reported to be robustly associated with BMI and related traits (48, 49) . The rs11642841 C allele associated positively with intake of total sugar (β = 0.928 g/d, SE = 0.169, P = 3.8 × 10 −8 ), inversely with BMI (β = −0.301 kg/m 2 , 1 DZ, dizygotic; gSweet, the general sweet factor (a weighted mean of ratings of glucose, fructose, NHDC, and aspartame); MZ, monozygotic; NHDC, neohesperidin dihydrochalcone. The Australian sample rated perceived intensity of sweet solutions using a general labeled magnitude scale; the US sample rated perceived intensity, sweetness, and liking for sucrose solution using a visual analog scale.
2 Intake of sweets was only collected from participants who reported consuming any biscuits (cookies), chocolate, or sweets (candies). 3 Based on the sample of 174,424 participants with intake of total sugars. SE = 0.010, P = 6.1 × 10 −211 ), but not with the intake of sweets (β = 0.002 handfuls/d, SE = 0.010, P = 0.84), in the UK Biobank sample. The association between rs11642841 and the intake of total sugar remained strong after including BMI as a covariate (β = 0.772 g/d, SE = 0.169, P = 4.9 × 10 −6 ). We further examined the associations between the 3 traits and found that the intake of total sugars was negatively associated with BMI (r p = −0.04; 95% CI: −0.04, −0.03; r g = −0.23; 95% CI: −0.29, −0.17), whereas the intake of sweets was positively associated with BMI (r p = 0.09; 95% CI: 0.07, 0.10; r g = 0.67; 95% CI: −0.27, 1.00) at both phenotypic and genetic levels ( Table 3) .
There were several suggestive associations for each of the sweet taste phenotypes (P < 1.0 × 10 −5 ). In the Australian sample these included 7 independent associations for glucose intensity, 3 for fructose intensity, 13 for NHDC intensity, 6 for aspartame intensity, and 3 for gSweet (Figure 2, Supplemental  Table 2 ). In the US sample there were 10 associations for sucrose intensity, 14 for sucrose sweetness, and 13 for sucrose liking (Figure 3, Supplemental Table 3 ). The meta-analysis of gSweet for the Australian sample and sucrose intensity for the US sample showed 4 additional suggestive independent associations (Figure 4, Supplemental Table 4 ). We also found 53 suggestive associations for the intake of total sugars and 14 for the intake of sweets in the UK Biobank sample (Figure 1 , Supplemental Table  1 ). Information on each SNP including its location (chromosome and base pair), effect allele and non-effect allele, effect size (β, SE, percentage of variance accounted for), P value, and the nearest gene is reported in Supplemental Tables 1-4 .
We examined the cross-associations between all suggestively associated SNPs and sweet phenotypes. Whereas the SNPs identified in the Australian twins were associated with all 5 phenotypes in the same sample, and in the same direction, their associations with phenotypes in the US and the UK Biobank samples were mostly null ( Figure 5, Supplemental Table 5 ). Similarly, all SNPs identified in the US sample were associated with all 3 US phenotypes in the same direction but their associations with the phenotypes in the Australian and the UK Biobank samples were close to the null. Among the 4 SNPs identified in the meta-analysis of the gSweet in the Australian sample and sucrose intensity in the US sample, rs17457384 was associated with the intake of sweets in the UK Biobank sample (P = 0.004), with the allele associated with higher sweet intensity ratings being associated with a higher intake of sweets. Lastly, the SNPs identified in the UK Biobank sample were weakly or null associated with all other phenotypes in any sample (Supplemental Table 6 ).
In further functional analyses we found that 12 of the 139 suggestively associated SNPs (8 for the intake of total sugars, 1 for the intake of sweets, 1 for NHDC intensity, 1 for sucrose sweetness, and 1 for the meta-analysis of gSweet and sucrose intensity) were in high LD (r 2 ≥ 0.6) with nonsynonymous variants within protein coding (exonic) regions (Supplemental Table 7 ). All 12 SNPs were correlated with missense mutations; and 2 SNPs, rs62060920 and rs603985, which were suggestively associated with the intake of total sugars, were further correlated with nonsense mutations that create stop codons within the same gene (i.e., MAPT and FUT2, respectively).
Gene-based tests using fastBAT did not identify any significant association (see Supplemental Table 8 for the associations with P < 1.0 × 10 −5 ), whereas the results from MetaXcan showed a significant association between the intake of total sugars and the expression of FTO in the muscle tissue (P = 2.62 × 10 −8 ; see Supplemental Table 9 for the top associations). Pathway analyses showed that the perceived intensity of sucrose was associated with the stomach inflammation pathway (P = 2.2 × 10 −13 and false discovery rate < 0.05). Genes involved in this pathway were SLC50A1, AL645568.1 (RP11-296O14.3), CCDC68, GPBP1, EFNA1, NALT1 (RP11-611D20.2), B3GNTL1, CNTN5, FSHR, and WLS. No association in the tissue enrichment analyses reached the statistical significance threshold. The strongest FIGURE 1 Manhattan plots displaying the association -log 10 P value for each SNP in the genome and the intake of total sugars (grams per day; n = 174,424) (A) and the intake of sweets (handfuls of candies per day; n = 21,447) (B) in the UK Biobank white-British participants. Only the top SNP with P < 1.0 × 10 −5 for each chromosome is labeled. SNP, single nucleotide polymorphism. associations (P < 0.01) were found within the genitalia, muscles, connective tissues, pharynx, immune system, and central nervous system (Supplemental Table 10 ).
Associations with TAS1R2, TAS1R3, GNAT3, GLUT2, and FGF21
SNPs within TAS1R2, TAS1R3, and GNAT3 previously reported to be associated with the taste sensitivity of sucrose solution were not associated with any of the sweet perception or preference phenotypes in the Australian or US samples (P > 0.05 for all SNP associations, except for the association between TAS1R3 rs307055 and sucrose intensity ratings with P = 0.03; Supplemental Table 11 ; Supplemental Figure 3) . However, the TAS1R3 alleles associated with higher sucrose sensitivity tended to decrease ratings for all Australian and US sweet phenotypes.
SNPs within TAS1R2 and TAS1R3 were not associated with the intake of total sugars and sweets in the UK Biobank sample (P > 0.1). Because the associations between TAS1R2 rs35874116 and the intake of sugars were suggested to depend on BMI (6, 13), we followed previous studies by dividing the UK Biobank sample into 2 groups based on a BMI score of 25 (n = 109,507 and 64,554 for BMI ≥ 25 and < 25, respectively) or including BMI as a covariate, but no association was detected in any of the tests (P > 0.12). Six SNPs in high LD within the GNAT3 gene (rs1524600, rs6467217, rs6970107, rs6975345, rs10242727, and rs6467192; r 2 > 0.6 between the 6 SNPs) were marginally associated with the intake of total sugars (P < 0.05, Supplemental Table 11 ), with alleles associated with higher sucrose sensitivity leading to a lower intake. The GLUT2 rs5400 was not associated with the intake of total sugars and sweets (Supplemental Figure  4) and the null association remained after we included BMI as a covariate or stratified the UK Biobank sample by a BMI score of 25 (P > 0.05). We successfully replicated the association between FGF21 and intake, with the rs838133 A allele (β = 0.860 g/d, SE = 0.170, P = 4.8 × 10 −7 ) and rs838145 G allele (β = 0.782 g/d, SE = 0.167, P = 2.7 × 10 −6 ) leading to higher intake of total sugars.
Gene-based tests using fastBAT did not identify any significant associations between TAS1R2, TAS1R3, GNAT3, and GLUT2 and all phenotypes (P > 0.05), but there was a strong association between FGF21 and the intake of total sugar in the UK Biobank sample (P = 2.71 × 10 −6 ). MetaXcan results showed some marginal associations with P < 0.05 (Supplemental Table 9 ) and the strongest association was between the intake of total sugar and expression of TAS1R3 in brain tissue (P = 3.15 × 10 −4 ). Because the associations with TAS1R2, TAS1R3, GNAT3, and GLUT2 were reported previously in samples of unknown or mixed ethnicities, we wondered whether they were driven by population stratification, i.e., there are mean differences in the same sweet phenotype between populations and an artificial association is created due to the difference in the allele frequency between populations. We looked up their allele frequencies using the 1000 Genomes reference panel (50) and found that some of the allele frequencies, particularly for SNPs within TAS1R3, GNAT3, and GLUT2, are very different between African Americans and others ( Table 4) . Using the full sample of the UK Biobank, which is comprised of mixed ethnicities, we reproduced these associations with the intake of total sugars and sweets and even BMI, but the associations became null after adjusting for genetic PCs (Table 4 ) or after the sample was stratified by ethnic group (Supplemental Table 12 ). We FIGURE 3 Manhattan plots displaying the association -log 10 P value for each SNP in the genome and the perception of sucrose reported via ratings of intensity (A), sweetness (B), and liking (C) in 686 US adult twins and unpaired individuals. Only the top SNP with P < 1.0 × 10 −5 for each chromosome is labeled. SNP, single nucleotide polymorphism.
FIGURE 4
Manhattan plot for the meta-analysis of the perceived intensity of gSweet ( Figure 2E ) and sucrose ( Figure 3A) . The top single nucleotide polymorphism with P < 1.0 × 10 −5 for each chromosome is labeled. gSweet, general sweet factor (a weighted mean of ratings of glucose, fructose, neohesperidin dihydrochalcone, and aspartame).
showed an unexpected association between rs5400 and BMI (P = 1.04 × 10 −8 after adjusting for genetic PCs) and the association remained strong within the white-British-only subset of the UK Biobank (P = 2.7 × 10 −7 ).
Gene expression
We examined the expression levels of genes nearby the suggestively associated SNPs (Supplemental Tables 1-4) , genes containing nonsynonymous variants (Supplemental Table 7 ), those involved in the stomach inflammation pathway, and the 5 previously reported sweet taste genes (i.e., TAS1R2, TAS1R3, GNAT3, GLUT2 [SLC2A2], and FGF21). The expression levels of 133 genes and 121 genes were available in the in-house assays for the taste tissue and in the GTEx database for other tissues, respectively (presented as a heatmap in Supplemental Figure 5 ). In general, expression levels of the same gene were similar across all tissues. The 2 genes FUT2 and MAPT, which contain both missense and nonsense mutations, were expressed particularly higher in the salivary gland and the brain, respectively. The former was also expressed in the taste tissue at a moderate level, whereas the latter was barely expressed in the taste tissue. The sweet taste receptor gene TAS1R3 was weakly expressed across all tissues; the information on TAS1R2 and GNAT3 was only available in the in-house data on taste tissue and they were barely expressed.
Discussion
To our knowledge, this is the first large-scale GWAS of the perception, liking, and consumption of sweet substances using 3 independent population samples of Australian adolescents and US and UK adults. We found a strong association between the FTO gene and sugar intake, and suggestive associations for both the perception and intake of sweet substances. Whereas we replicated the association between the FGF21 gene and sugar intake, we found limited support for the previously reported associations within the TAS1R2, TAS1R3, GNAT3, and GLUT2 genes.
The SNP associated with sugar intake (rs11642841) is highly correlated with the repeatedly reported BMI-associated SNP rs9939609 within the FTO gene (48) (r 2 = 0.73 in the UK Biobank white-British sample). The BMI-increasing allele has been shown to increase the intake of energy (51, 52) , dietary fat (53), and protein (54); the risk of cardiometabolic disorders (e.g., type 2 diabetes, coronary artery disease, and hypertension); and fasting glucose and insulin concentrations (55) . Counterintuitively, in the present study the BMI-increasing allele was associated with a lower intake of reported total sugars. We further found negative genetic and phenotypic correlations between sugar intake and BMI in the UK Biobank sample, in agreement with an earlier observational study (56) . These negative associations could be because obese people derive a greater proportion of energy from protein and fat and less from carbohydrates (57) . There may also be reporting bias, with those who have greater BMI tending to underreport sugar intake, or the possibility that our result is a chance finding because we did not find information to replicate these associations in other independent studies. In contrast, the intake of sweets, which contributed to a part of the total sugars, and BMI were positively correlated. This suggests that people who are overweight or obese reduce calories by reducing the intake of total carbohydrates but they still eat more sweets than people with normal weight.
We showed evidence of nonsynonymous variants associated with both perception and intake of sweet substances. Particularly, 2 SNPs (rs62060920 and rs603985) associated with sugar intake were correlated with not only amino acid-changing variants but also stop codon-creating variants within the same genes, i.e., MAPT and FUT2, respectively. Expression levels of these 2 genes MAPT and FUT2 were higher in the brain and the salivary gland, respectively, suggestive of their roles in central and peripheral 1.04 × 10
Allele frequencies for AFR, AMR, ASN, and EUR are based on the 1000 Genome reference panel. n = 206,551 for the intake of total sugar; n = 20,532 for the intake of sweets; n = 485,476 for BMI. See Supplemental Table 12 for the ancestral demography of the UK Biobank. AFR, African; AMR, Admixed American (i.e., Colombian, Puerto Rican, and Mexican individuals); ASN, Asian; EUR, European; P, association P value for an SNP and a trait; PC, principal component; SNP:allele, single nucleotide polymorphism and the allele used to calculate allele frequency; UKB, UK Biobank.
2 P = 2.7 × 10 −7 in all the Europeans from the UK Biobank (n = 407,708).
mechanisms regulating sugar intake. Another SNP, rs623965, identified in the meta-analysis of sweet intensity and which is correlated with a nonsynonymous variant within the KDMA4 gene, was recently shown to be associated with educational attainment (P = 3.8 × 10 −7 ) (58). This suggests a shared molecular mechanism for the sweet taste perception and cognitive function, which can be indirectly supported by our recent finding of the phenotypic correlation between intelligence and gSweet (r p = −0.07, P < 0.05) (32) . These results highlight the potential significance of the brain in the perception and intake of sweet substances.
We failed to replicate the associations between sweet taste perception and variants within the TAS1R2, TAS1R3, and GNAT3 genes in all 3 samples of European ancestry. Previous studies reported these associations in smaller samples (n = 95 [6] , 144 [7] , and 160 [8] ); moreover, 2 of these samples (7, 8) were comprised of mixed ethnicities (i.e., Europeans, Asians, and African Americans), in which the allele frequencies vary (Table 4) , and 1 was of unknown ethnicity (6) . Their analyses did not include genetic PCs to account for population stratification because no genome-wide genotyping data were available and it was unclear whether ethnicity was included as a covariate. Using the full UK Biobank sample including mixed ethnicities, we reproduced the associations with TAS1R3 and GNAT3; however, the associations became null after adjusting for genetic PCs, suggesting that spurious associations may arise for these particular SNPs if population stratification is not considered appropriately. This is why we could not replicate these associations in the European-only populations. Nevertheless, the effect of TAS1R3 on sucrose preference was observed in an independent adult female sample primarily composed of African Americans (16) , indicating that the TAS1R3 SNPs could have functional potency for sweet taste perception within other ethnic groups. It is noteworthy that the same genetic variants might affect sweet perception and intake differently in different populations of the same genetic ancestry owing to cultural differences, especially those populations having traditional compared with obesogenic foodways. Therefore, an ideal study design needs to consider the effect of genetic ethnicity as well as the gene × environment interactions.
In agreement with previous studies we observed no association between the intake of sugars and sweet food and TAS1R3, but we failed to replicate the associations with TAS1R2 (6, (9) (10) (11) (12) (13) (14) and GLUT2 (13, 17) in the large UK Biobank sample. As some of these study samples were of mixed ethnicities, we demonstrated that an artificial association with sugar intake and even BMI could be created by population stratification (Table 4) . We found unexpectedly an association between GLUT2 rs5400 and BMI (P = 2.7 × 10 −7 among white-British individuals in the UK Biobank sample). However, this association is relatively weak in an equally large European sample (P = 0.019) (59) and is not in the top 751 independent associations in today's largest GWAS meta-analysis of BMI (n = ∼700,000 Europeans including participants from the UK Biobank) (60), so its effect on BMI requires further investigation.
Among the SNPs suggestively associated with sweet taste perception, rs17457384 near the GABRB2 gene was associated with the intake of sweets in the UK Biobank sample. This SNP was identified in the meta-analysis of sweet intensity, with the T allele being associated with a higher perceived intensity rating of gSweet (Australian sample) and sucrose (US sample) and a higher intake of sweets (UK Biobank sample). The GABRB2-encoded protein is a receptor of neurotransmitters that mediate synaptic transmission in the central nervous system and it is 
FIGURE 5
Heatmap showing the effect of SNP on the perceived intensity of glucose, fructose, NHDC, aspartame, and gSweet in the Australian sample, the perceived intensity, sweetness, and liking for sucrose in the US sample, and the intake of sugars (grams per day) and sweets (handfuls of candies per day) in the UK Biobank. Effect sizes are presented as β/SE (see Supplemental  Table 5 for details) and range from −2.63 to 5.2, with negative and positive values coded in blue and red colors, respectively. SNPs identified in the Australian sample affect all 5 Australian phenotypes in the same direction and those identified in the US sample affect all 3 US phenotypes in the same direction. Although these effects appear to be sample-specific, meta-analysis identified 4 additional SNPs that have similar effects in both samples, of which rs17457384 is associated with sweets intake in the UK Biobank, with the allele for higher intensity ratings leading to a lower intake. gSweet, general sweet factor (a weighted mean of ratings of glucose, fructose, NHDC, and aspartame); NHDC, neohesperidin dihydrochalcone; SNP, single nucleotide polymorphism. * , P < 0.05; * * , P < 1.0 × 10 −5 ; −, SNP not available.
highly expressed in the brain. This finding again signifies the neurological influence on sweet consumption.
Differences in the association patterns between the Australian adolescent and the US adult samples could be due to differences in their study characteristics, including the sample age (i.e., mean ages were 16.1 compared with 36.8 y) and the measuring scale (i.e., gLMS compared with VAS). We previously showed that the perceived intensity of sweet solutions decreased from adolescents to adults at a rate of 2-5%/y between ages 12 and 25 y (5). Measuring sweet taste phenotypes using gLMS and VAS could lead to different data distributions (61) . These together make replications more difficult when the sample sizes are not big enough. Notably, the genome-wide significant associations for the bitter taste perception (i.e., rs713598, rs1726866, and rs10246939 for propylthiouracil/phenylthiocarbamide and rs10772420 for quinine [29, 62, 63] ) were consistent between the 2 samples (Supplemental Table 13 ). This indicates that the genetics of sweet taste is more complicated and our findings require further validation in larger samples.
Pathway analyses showed that the cellular process related to stomach inflammation is associated with the perceived intensity of sucrose in the US adult sample. Alteration in taste is one of the symptoms of stomach gastritis (64, 65) and the association might be linked via reflux or vomiting, which expose taste receptors in the oral cavity to gastric acid (66) . Mouse studies have shown that taste receptors expressed in the stomach can modify gastric motility and food intake (67, 68) . As human sweet taste receptors (i.e., TAS1R3; Supplemental Figure 5 ) are also expressed along the gastrointestinal tract, perhaps molecules involved in stomach inflammation could regulate the function of sweet taste receptors, which in turn influences taste perception.
Despite our samples being considerably larger than any previous studies of the associations we have examined, the present study may still lack statistical power. In particular, we were unable to detect genome-wide significant associations for sweet taste perception. This suggests that sweet taste is a polygenic trait and its variation is influenced by many SNPs, each with a small effect. Genetically informative data on taste perception are relatively limited compared with disease traits or other sensory traits, such as vision (69) or hearing (70) . This is presumably due to variation in taste perception posing no immediate threat to life, or to a lesser extent. There are large genetic studies collecting food intake data (e.g., UK Biobank), which may be used as proxies of taste perception. However, our results indicate that the genetic profiles of intake of sweets can be different from those of sweet perception. Therefore, using the dietary data may not accurately capture individual differences in taste perception and is less likely to detect the true underlying genes, which highlights the value of our data sets.
In conclusion, this GWAS study showed an association between FTO and the intake of total sugars, suggestive of shared biology between the sugar consumption and BMI-related traits.
Findings from the present study were solely based on Europeans, so whether they can be generalized to other ethnic groups requires further investigation. The failure to replicate the associations with TAS1R2, TAS1R3, GNAT3, and GLUT2 warrants future studies using people with different ancestral backgrounds, such as Africans and Asians. Lastly, our results suggest that genes apart from those within the peripheral sweet receptor system are also associated with the perception and intake of sweet substances and those involved in brain functions and stomach inflammation could be a direction for future research.
